Related references
Note: Only part of the references are listed.Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level
Kumi Oshima et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: A single-center experience
S Wasson et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal
D Ranjan et al.
CELL BIOCHEMISTRY AND FUNCTION (2006)
Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome
H Tanaka et al.
PEDIATRIC NEPHROLOGY (2004)
The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats
HH Hagar
TOXICOLOGY LETTERS (2004)
The pharmacokinetics of equoral versus Neoral in stable renal transplant patients: A multinational multicenter study
MA Masri et al.
TRANSPLANTATION PROCEEDINGS (2004)
Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression
CG Chen et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Attenuation of cyclosporine-induced renal dysfunction by catechin: Possible antioxidant mechanism
M Anjaneyulu et al.
RENAL FAILURE (2003)
The effects of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues
I Durak et al.
TRANSPLANT IMMUNOLOGY (2002)
Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane
C Fimognari et al.
CARCINOGENESIS (2002)
Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells
CG Chen et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Protein oxidation in the brain in Alzheimer's disease
MY Aksenov et al.
NEUROSCIENCE (2001)
Share Paper
